Testing effectiveness (Phase 2)WithdrawnNCT05007769
What this trial is testing
Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC
Who this might be right for
Non-small Cell Lung CancerNon-small Cell CarcinomaNSCLC+1 more
Washington University School of Medicine